Article Information
History
- January 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kapil K. Saharia1,2,
- Jennifer S. Husson1,2,
- Silke V. Niederhaus3,
- Thierry Iraguha4,
- Stephanie V. Avila4,
- Youngchae J. Yoo1,
- Nancy M. Hardy4,
- Xiaoxuan Fan5,
- Destiny Omili4,
- Alice Crane3,
- Amber Carrier3,
- Wen Y. Xie6,
- Erica Vander Mause4,
- Kim Hankey4,
- Sheri Bauman4,
- Patricia Lesho4,
- Heather D. Mannuel5,7,
- Ashish Ahuja8,
- Minu Mathew2,
- James Avruch3,
- John Baddley1,2,5,
- Olga Goloubeva9,
- Kirti Shetty10,
- Saurabh Dahiya4,
- Aaron P. Rapoport4,
- Tim Luetkens4,11 and
- Djordje Atanackovic4,11,*
- 1Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD
- 2Divison of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD
- 3Department of Surgery, University of Maryland School of Medicine, Baltimore, MD
- 4Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland
- 5University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
- 6Department of Surgery, University of Florida College of Medicine, Gainesville, FL
- 7Baltimore Veterans Affairs Medical Center, Baltimore, MD
- 8Department of Medicine, University of Maryland Medical Center, Baltimore, MD
- 9Department of Epidemiology and Public Health, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
- 10Division of Hepatology/Liver Transplantation, University of Maryland School of Medicine, Baltimore, MD
- 11Department of Microbiology and Immunology, University of Maryland, Baltimore, MD
- ↵*Corresponding author: Djordje Atanackovic, MD, Director, Cancer Immunotherapy, Medical Director, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD 21201, Email: datanackovic{at}som.umaryland.edu
Posted January 01, 2022.
Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine
